Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with T
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q3 2022 | TOCOPHEROL | ORAL | CAPSULE | 4.00 mg | Correction | ||
| Q4 2022 | TOCOPHEROL | ORAL | CAPSULE | NA | Correction | ||
| Q3 2022 | TRISODIUM CITRATE DIHYDRATE | ORAL | SUSPENSION | 4950mg | Correction | ||
| Q4 2022 | TRISODIUM CITRATE DIHYDRATE | ORAL | SUSPENSION | 947mg | Correction | ||
| Q4 2022 | TALC | ORAL | LIQUID, EXTENDED RELEASE | 3.83 mg/ 1.00 ml | 46mg | Deletion | |
| Q4 2022 | TALC | ORAL | TABLET, COATED PARTICLES | 6.50 mg | 39mg | Deletion | |
| Q4 2022 | TRIETHYL CITRATE | ORAL | LIQUID, EXTENDED RELEASE | 0.42 mg/ 1.00 ml | 5mg | Deletion |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: October 1, 2022
Database Last Updated: October 19, 2022